|
Volumn 44, Issue 4, 2001, Pages 512-523
|
Reduction in glucose levels in STZ diabetic rats by 4-(2,2-Dimethyl-1-oxopropyl)benzoic acid: A prodrug approach for targeting the liver
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (1,1 DIMETHYLETHYL) 2 (4 METHYLPHENYL) 1,3 DIOXOLANE;
4 (2,2 DIMETHYL 1 OXOPROPYL)BENZOIC ACID;
FATTY ACID;
GLUCOSE;
PRODRUG;
SAH 51641;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ABSORPTION;
ADIPOCYTE;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
AUTOIMMUNITY;
FATTY ACID METABOLISM;
GLUCONEOGENESIS;
HYPERGLYCEMIA;
LIPID METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OXIDATION;
RAT;
STREPTOZOCIN DIABETES;
ANIMALS;
AREA UNDER CURVE;
BENZOATES;
BENZOIC ACIDS;
BLOOD GLUCOSE;
DIABETES MELLITUS, EXPERIMENTAL;
FATTY ACIDS;
HEPATOCYTES;
HYPOGLYCEMIC AGENTS;
LIVER;
MALE;
OXIDATION-REDUCTION;
PRODRUGS;
RATS;
RATS, SPRAGUE-DAWLEY;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035865907
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm000264w Document Type: Article |
Times cited : (13)
|
References (35)
|